CompletedPhase 3

Allograft Transplantation in the Treatment of Osteoarthritis of the Metatarsophalangeal (MTP) Joint of the Great Toe

United States24 participantsStarted 2010-09

Plain-language summary

Using the concept of an implant acting as a spacer and stabilizer, the proposed study will evaluate the use of allograft knee meniscus in the treatment of MTP joint osteoarthritis of the great toe.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * symptomatic of stage 3 osteoarthritis of the great toe * symptoms recalcitrant to nonoperative management as determined clinically by the principal investigator Exclusion Criteria: * diabetes mellitus * kidney insufficiency * oa in the adjacent joints * malignancy with in the past 10 yrs * minors (\< 18 yrs of age) * pregnant women and fetus * mentally disabled or cognitively impaired individuals

What they're measuring

Allograft Stability

Timeframe: 5-years postoperative

Trial details

NCT IDNCT01673347

SponsorPaul Fortin, MD

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-05

Results submitted2017-04-19

View on ClinicalTrials.gov More Osteoarthritis trials